Detalhe da pesquisa
1.
Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.
Oncologist
; 28(11): e1075-e1091, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358877
2.
Treatment patterns and outcomes associated with sequential and non-sequential use of CDK4 & 6 inhibitors in patients with HR+, HER2- MBC in the real world.
Breast Cancer Res Treat
; 201(1): 105-115, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310540
3.
Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United Kingdom.
Eur J Cancer Care (Engl)
; 27(5): e12862, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29927010
4.
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.
Invest New Drugs
; 34(5): 625-35, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27350064
5.
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.
Health Qual Life Outcomes
; 14: 52, 2016 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27016084
6.
Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.
BMC Health Serv Res
; 14: 555, 2014 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25392276
7.
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
Adv Ther
; 40(5): 2515-2523, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995468
8.
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
Drugs Real World Outcomes
; 10(4): 589-603, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37775689
9.
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.
Drugs Real World Outcomes
; 9(4): 681-693, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097254
10.
Clinical Characteristics, Treatments, and Concurrent Mutations in Non-Small Cell Lung Cancer Patients With NF1 Mutations.
Clin Lung Cancer
; 22(1): 32-41.e1, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221173
11.
Development of a Prognostic Factor Index Among Women With HR+/HER2- Metastatic Breast Cancer in a Community Oncology Setting.
Clin Breast Cancer
; 21(4): 317-328.e7, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33678566
12.
A review of health technology appraisals: case studies in oncology.
Int J Technol Assess Health Care
; 29(1): 101-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23270645
13.
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study.
Clin Ther
; 37(6): 1301-16, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907619
14.
A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma.
Dermatol Ther (Heidelb)
; 5(3): 183-99, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26324194